DaVita HealthCare Partners Inc DVA:NYSE (Common Stock)
| Last | Change / % Change | Dividend Yield | Volume | Avg Volume (10 day) |
|---|---|---|---|---|
| 72.75 | 0.72 1.00% | 826,805 | 1.0M |
Latest News Headlines for DaVita HealthCare Partners Inc
Company's 150th 'Academy' hosts nearly 2,000 teammates, dignitaries in Denver DENVER, Oct. 17, 2014 /PRNewswire/ -- DaVita HealthCare Partners Inc. (NYSE: DVA), one of the nation's largest and most innovative health care communities, recently held its 150th DaVita University Academy -- the company's award-winning, leadership development and cultural orientation program for new teammates. Nearly 2,000 DaVita teammates from around the globe were in attendance for the event.
DENVER, Oct. 16, 2014 /PRNewswire/ -- DaVita HealthCare Partners Inc. (NYSE: DVA) announced today that it will hold its quarterly conference call to discuss third quarter results on Thursday, Nov. 6, 2014, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day.
DENVER, Oct. 16, 2014 /PRNewswire-USNewswire/ -- DaVita HealthCare Partners Inc. (NYSE: DVA), one of the nation's largest and most innovative health care communities, today announced that the Reputation Institute ranked DaVita HealthCare Partners 37(th) overall in its global rankings, according to a recent article in Harvard Business Review (HBR).
Latest Annual and Quarterly SEC Filings
More FilingsCompany Background
DaVita HealthCare Partners Inc., formerly DaVita Inc., is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December 31, 2011, the Company provided dialysis and administrative services through a network of 1,809 outpatient dialysis centers located in the United States throughout 43 states and the District of Columbia, serving a total of approximately 142,000 patients. It also provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services throughout the United States. In July 2013, DaVita, a division of DaVita HealthCare Partners Inc announced the acquisition of the dialysis operations of Malaysia's Caring Dialysis Centre Group (CDC Group) by DVA (Malaysia) Sdn Bhd.
collapse, right-facing arrow indicating collapsed view of sectionOverview
| Bid | Size | -- | -- |
|---|---|
| Ask | Size | -- | -- |
| Price Open | 72.66 |
| Previous Close | 72.03 |
| Day High | 72.98 |
| Day Low | 72.13 |
| 52 Week High | 10/9/2014 | 75.385 |
| 52 Week Low | 11/6/2013 | 52.752 |
| % Off 52 Week High | -3.50% |
| % Off 52 Week Low | 37.91% |
| Beta (5 Yr) | 0.66 |
| Volatility Avg | 10/17/2014 | 19.00 |
| 10-Day Avg. Volume | 1,030,901 |
| Market data is delayed by at least 20 minutes. | |
collapse, right-facing arrow indicating collapsed view of sectionFundamentals
| EPS (TTM) | 6/30/2014 | 3.15 |
|---|---|
| P/E Ratio | 6/30/2014 | 23.1 |
| Market Cap | Large Cap | 15.6B |
| Shares Outstanding | 214.80M |
| Float | 208.9M |
collapse, right-facing arrow indicating collapsed view of sectionDividends
| Dividend Yield | -- |
|---|---|
| Ex-Date | -- |
| Dividend Announcement | -- |
| Date of Record | -- |
| Payable | -- - -- |
| Payable Date | -- |
Peers Information HelpDVA DaVita HealthCare Partners Inc vs. Peers
| Peers | |
|---|---|
DVA DaVita HealthCare Partners Inc | 14.80% |
Quest Diagnostics Inc | 9.84% |
Laboratory Corp. of America Holdings | 7.99% |
RadNet Inc. | 407.78% |
Bio-Reference Laboratories Inc | 10.57% |
DVA DaVita HealthCare Partners Inc | 0.00% |
Quest Diagnostics Inc | 2.24% |
Laboratory Corp. of America Holdings | -- |
RadNet Inc. | -- |
Bio-Reference Laboratories Inc | -- |
DVA DaVita HealthCare Partners Inc | 1.00% |
Quest Diagnostics Inc | 1.52% |
Laboratory Corp. of America Holdings | 0.67% |
RadNet Inc. | 2.54% |
Bio-Reference Laboratories Inc | -0.70% |